Delirium Clinical Trial
Official title:
The Prevention of Delirium and Complications Associated With Surgical Treatments Multi Center Clinical Trial
Delirium is a medical term or condition that includes a temporary inability to focus attention and to think clearly. Delirium occurs commonly (10% to 70%) in patients older than 60 undergoing large surgeries. The purpose of this study is to test rigorously whether a drug called ketamine can decrease the chance that patients will experience delirium after their surgery. The investigators are also testing whether ketamine decreases postoperative pain, postoperative opioid consumption, postoperative nausea and vomiting, ICU and hospital length of stay, and adverse outcomes (e.g. hallucinations and nightmares).
Postoperative delirium is one of the most common complications of major surgery, affecting
between 10% and 70% of all elderly surgical patients. Delirium manifests as poor attention
and inability to think logically, and is associated with longer intensive care unit and
hospital stay, long lasting cognitive deterioration, and increased mortality rate. Studies
have shown that a low sub-anesthetic dose of ketamine, an anesthetic drug, has the potential
to decrease several postoperative complications, including delirium, pain, opioid
consumption, and nausea and vomiting. Low dose ketamine would be particularly appealing as a
drug to prevent delirium and other postoperative complications, as it is inexpensive and
extremely safe. However, these proposed benefits of ketamine in the perioperative setting
have not yet been tested in a large clinical trial. The investigators are therefore proposing
a pragmatic, exploratory clinical trial to support or refute the contention that low dose
ketamine decreases the incidence of postoperative delirium, with the possibility of
conducting a larger randomized clinical trial pending the results of this study. At the time
of enrollment, patients will undergo the same delirium and pain evaluation that will be used
postoperatively. Additionally patients will be screened for functional dependence using the
Barthel Index of Activities of Daily Living, for depression using the Geriatric Depression
Scale - Short Form, and for obstructive sleep apnea using the STOP-Bang criteria. They will
also be asked about any falls they have experienced in the six months prior to surgery.
Comorbid conditions, including the components of the Charlson Comorbidity Index, will be
obtained by reviewing the patients' medical records. Any available preoperative lab results,
including electrolytes and blood counts, will also be recorded.
Patients will be randomized to receive low dose ketamine or placebo following induction of
anesthesia and prior to surgical incision. Blinded observers will assess delirium on the
afternoon/evening of postoperative day 0 (if feasible) and twice daily (morning and
afternoon/evening with at least six hours between assessments) on postoperative days 1-3
using the Confusion Assessment Method or the Confusion Assessment Method for Intensive Care
Unit. Acute pain will be assessed via the observer-based Behavioral Pain Scale or Behavioral
Pain Scale (Non-Intubated) with subsequent administration of the patient-reported Visual
Analog Scale from postoperative days 0-3. Postoperative opioid consumption will be assessed
from the patients' medical charts for postoperative days 0-3. Postoperative nausea and
vomiting will be assessed via a patient-reported section of the Behavioral Pain Scale or
Behavioral Pain Scale (Non-Intubated) for postoperative days 0-3. ICU and/or hospital length
of stay will be assessed from the patients' medical charts. Adverse outcomes (e.g.
hallucinations and nightmares) will be assessed via the Confusion Assessment Method or the
Confusion Assessment Method for Intensive Care Unit for postoperative days 0-3.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04551508 -
Delirium Screening 3 Methods Study
|
||
Recruiting |
NCT05891873 -
Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations
|
||
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT04792983 -
Cognition and the Immunology of Postoperative Outcomes
|
||
Recruiting |
NCT06194474 -
Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients
|
||
Completed |
NCT03095417 -
Improving the Recovery and Outcome Every Day After the ICU
|
N/A | |
Completed |
NCT05395559 -
Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
|
||
Terminated |
NCT03337282 -
Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
|
||
Not yet recruiting |
NCT04846023 -
Pediatric Delirium Screening in the PICU Via EEG
|
N/A | |
Not yet recruiting |
NCT04538469 -
Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
|
||
Not yet recruiting |
NCT03807388 -
ReMindCare App for Patients From First Episode of Psychosis Unit.
|
N/A | |
Withdrawn |
NCT02673450 -
PER3 Clock Gene Polymorphism, Clock Gene Expression and Delirium in the Intensive Care Unit.
|
||
Recruiting |
NCT03256500 -
Transcranial Direct Current Stimulation for the Treatment of Delirium
|
N/A | |
Completed |
NCT02890927 -
Geriatric-CO-mAnagement for Cardiology Patients in the Hospital
|
N/A | |
Not yet recruiting |
NCT02892968 -
ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients
|
N/A | |
Recruiting |
NCT03165539 -
Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
|
||
Completed |
NCT02518646 -
DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models
|
N/A | |
Completed |
NCT02554253 -
The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction
|
Phase 2 | |
Recruiting |
NCT02305589 -
The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium
|
N/A | |
Completed |
NCT02628925 -
Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale
|
N/A |